QR-Code

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]

<p>Abstract</p> <p>Background</p> <p>Raised levels of both triglycerides and fibrinogen, each of which are reduced by bezafibrate, may contribute to lower extremity arterial disease (LEAD). This condition is characterized by a particularly high incidence of coronary heart disease (CHD) and stroke, b...

Ausführliche Beschreibung

Gespeichert in:
1. Verfasser: Meade Thomas W
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2001-07-01
Schriftenreihe:Current Controlled Trials in Cardiovascular Medicine
Schlagworte:
arterial disease
bezafibrate
fibrinogen
lipid profile
Online-Zugang:http://cvm.controlled-trials.com/content/2/4/195
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge